NCT06962852View on ClinicalTrials.gov

A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

July 17, 2048

Study Completion Date

July 17, 2048

Conditions
Cystic Fibrosis
Interventions
GENETIC

BI 3720931

BI 3720931

Trial Locations (10)

16147

NOT_YET_RECRUITING

Istituto G. Gaslini, Genova

34295

RECRUITING

HOP Gui de Chauliac, Montpellier

75015

NOT_YET_RECRUITING

HOP Necker, Paris

00165

RECRUITING

Osp. Pediatrico Bambin Gesù, Roma

3584 CX

NOT_YET_RECRUITING

Universitair Medisch Centrum Utrecht, Utrecht

08035

NOT_YET_RECRUITING

Hospital Vall d'Hebron, Barcelona

CF64 2XX

NOT_YET_RECRUITING

University Hospital Llandough, Cardiff

G51 4TF

NOT_YET_RECRUITING

Queen Elizabeth University Hospital, Glasgow

SW3 6JY

RECRUITING

Royal Brompton Hospital, London

M23 9LT

NOT_YET_RECRUITING

Wythenshawe Hospital, Manchester

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY